{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=T2D+medication+management", "query": { "intervention": "T2D medication management" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 159, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=T2D+medication+management&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T23:19:35.483Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03713684", "title": "Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Efpeglenatide SAR439977", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Background therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 370, "start_date": "2018-11-09", "completion_date": "2021-01-04", "has_results": true, "last_update_posted_date": "2021-12-02", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Glendale, Arizona + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Huntington Park", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03713684" }, { "nct_id": "NCT06363747", "title": "The Medically Reproducing Bariatric Surgery (MRB) II Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Type 2 Diabetes", "Obesity" ], "interventions": [ { "name": "Very Low Calorie Diet", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Durham VA Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "25 Years to 75 Years" }, "enrollment_count": 50, "start_date": "2024-06-24", "completion_date": "2025-11-03", "has_results": false, "last_update_posted_date": "2025-02-07", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 1, "location_summary": "Greenville, North Carolina", "locations": [ { "city": "Greenville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06363747" }, { "nct_id": "NCT01768559", "title": "Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Lixisenatide (AVE0010)", "type": "DRUG" }, { "name": "Insulin glulisine QD", "type": "DRUG" }, { "name": "Insulin glulisine TID", "type": "DRUG" }, { "name": "Insulin Glargine (Mandatory background drug)", "type": "DRUG" }, { "name": "Metformin (Background drug)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 894, "start_date": "2013-01", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2017-01-04", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 46, "location_summary": "Sun City, Arizona • Tempe, Arizona • Little Rock, Arkansas + 41 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Mesa", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01768559" }, { "nct_id": "NCT02128854", "title": "Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2", "Diabetes Mellitus, Adult-Onset", "Diabetes Mellitus, Non-Insulin-Dependent", "Diabetes Mellitus, Noninsulin Dependent", "Diabetes Mellitus, Type II" ], "interventions": [ { "name": "Tablets Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "45 Years to 100 Years" }, "enrollment_count": 60, "start_date": "2014-08-14", "completion_date": "2016-08-31", "has_results": false, "last_update_posted_date": "2017-05-09", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02128854" }, { "nct_id": "NCT02741050", "title": "Primary Care-Based Physical Activity for Diabetic Latinas", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes", "Sedentary Lifestyle" ], "interventions": [ { "name": "Tailored Physical Activity Intervention", "type": "BEHAVIORAL" }, { "name": "Standard of Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 25, "start_date": "2016-08", "completion_date": "2019-10", "has_results": false, "last_update_posted_date": "2020-01-13", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02741050" }, { "nct_id": "NCT03092063", "title": "Using Multifamily Groups to Improve Self-Management of Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type2 Diabetes" ], "interventions": [ { "name": "Tomando Control-Nurse", "type": "BEHAVIORAL" }, { "name": "Tomando Control-Promotora", "type": "BEHAVIORAL" }, { "name": "Enhanced engagement", "type": "BEHAVIORAL" }, { "name": "Multifamily Group", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 330, "start_date": "2017-03-01", "completion_date": "2021-07-31", "has_results": false, "last_update_posted_date": "2021-09-29", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 1, "location_summary": "Sylmar, California", "locations": [ { "city": "Sylmar", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03092063" }, { "nct_id": "NCT07053319", "title": "SGLT2i, Pioglitazone, and Ketone Production in T2D", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Empagliflozin 25 MG", "type": "DRUG" }, { "name": "Pioglitazone 15 mg increased to 30 mg after 2 weeks plus Empagliflozin Placebo", "type": "DRUG" }, { "name": "Empagliflozin 25 mg/d plus Pioglitazone (15/30 mg/d)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "30 Years to 75 Years" }, "enrollment_count": 64, "start_date": "2026-05-11", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07053319" }, { "nct_id": "NCT01236404", "title": "Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Single Subcutaneous Dose (Part A) of PB1023 or Placebo (0.9% NaCl)", "type": "DRUG" }, { "name": "Multiple (Four Weekly) Subcutaneous Injections (Part B) of PB1023 or Placebo (0.9% NaCl)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PhaseBio Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 80, "start_date": "2010-11", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2013-05-21", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 3, "location_summary": "Walnut Creek, California • Saint Paul, Minnesota • Renton, Washington", "locations": [ { "city": "Walnut Creek", "state": "California" }, { "city": "Saint Paul", "state": "Minnesota" }, { "city": "Renton", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01236404" }, { "nct_id": "NCT07654374", "title": "A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity", "Overweight", "Chronic Weight Management", "Type2 Diabetes Mellitus" ], "interventions": [ { "name": "aleniglipron", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 1100, "start_date": "2026-07-17", "completion_date": "2028-11", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 74, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Phoenix, Arizona + 68 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City West", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07654374" }, { "nct_id": "NCT03270085", "title": "Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Diarrhea", "Irritable Bowel Syndrome With Diarrhea", "Bile Acid Malabsorption" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2017-12-07", "completion_date": "2019-05-31", "has_results": true, "last_update_posted_date": "2020-04-27", "last_synced_at": "2026-09-03T23:19:35.483Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03270085" } ] }